FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978278577> ?p ?o ?g. }

• W1978278577 endingPage "45" @default.
• W1978278577 startingPage "39" @default.
• W1978278577 abstract "This trial was undertaken to study the effect of intensified intravenous cyclophosphamide/cisplatin and interim surgical debulking, followed by intraperitoneal cisplatin on surgically defined complete remission rate and survival in advanced ovarian cancer.Forty patients with stage IIB through IV ovarian cancer were entered and 36 were evaluable for response and survival and approximately 10 years. Following a first laparotomy for diagnosis and debulking, the patients received two cycles, spaced 28 days apart, of intravenous cisplatin 30-40 mg/m2/day with hypertonic saline for 4 to 5 days and cyclophosphamide 200 mg/m2/day for 5 days. A second laparotomy was done to further debulk remaining cancer and to place an intraperitoneal catheter. Four cycles of intraperitoneal cisplatin at 50 or 100 mg/m2 were administered 21 days apart and followed by a third laparotomy to define response and plan any further therapy.The surgically confirmed complete response rate was 47% and median survival is 68.3 months for this group. Ten of the 17 patients (58.8%) relapsed following complete response at a median of 19.5 months (range, 5-98). Both aggressive chemotherapy and surgery seemed to play a role in inducing this high complete response rate. Traditional prognostic factors, including stage and diameter of largest residual disease, had little apparent effect on likelihood of complete response or survival, whereas tumor grade had a more significant effect on survival. Nadir fever was experienced by 33% of patients but peripheral neuropathy was dose limiting.In the context of recent data failing to support any clinical benefit to modest increases in dose escalations of cisplatin or carboplatin, in this trial the high complete response rate suggests that the multimodality approach (i.e., interval surgical debulking and intraperitoneal cisplatin) is worthy of further study. The high relapse rate among complete responders and the unacceptable neurotoxicity also suggest that modifications could improve the results. The use of newer agents and further intensification (substituting carboplatin for cisplatin and the use of paclitaxel) with stem cell support are two examples." @default.
• W1978278577 created "2016-06-24" @default.
• W1978278577 creator A5012517342 @default.
• W1978278577 creator A5017271527 @default.
• W1978278577 creator A5023020931 @default.
• W1978278577 creator A5035446911 @default.
• W1978278577 creator A5051707990 @default.
• W1978278577 creator A5067734724 @default.
• W1978278577 creator A5073323475 @default.
• W1978278577 creator A5086908552 @default.
• W1978278577 date "1997-10-01" @default.
• W1978278577 modified "2023-10-13" @default.
• W1978278577 title "High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up" @default.
• W1978278577 doi "https://doi.org/10.1006/gyno.1997.4821" @default.
• W1978278577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9345354" @default.
• W1978278577 hasPublicationYear "1997" @default.
• W1978278577 type Work @default.
• W1978278577 sameAs 1978278577 @default.
• W1978278577 citedByCount "24" @default.
• W1978278577 countsByYear W19782785772015 @default.
• W1978278577 countsByYear W19782785772016 @default.
• W1978278577 crossrefType "journal-article" @default.
• W1978278577 hasAuthorship W1978278577A5012517342 @default.
• W1978278577 hasAuthorship W1978278577A5017271527 @default.
• W1978278577 hasAuthorship W1978278577A5023020931 @default.
• W1978278577 hasAuthorship W1978278577A5035446911 @default.
• W1978278577 hasAuthorship W1978278577A5051707990 @default.
• W1978278577 hasAuthorship W1978278577A5067734724 @default.
• W1978278577 hasAuthorship W1978278577A5073323475 @default.
• W1978278577 hasAuthorship W1978278577A5086908552 @default.
• W1978278577 hasConcept C121608353 @default.
• W1978278577 hasConcept C126322002 @default.
• W1978278577 hasConcept C141071460 @default.
• W1978278577 hasConcept C2776283816 @default.
• W1978278577 hasConcept C2776694085 @default.
• W1978278577 hasConcept C2776755627 @default.
• W1978278577 hasConcept C2778239845 @default.
• W1978278577 hasConcept C2780427987 @default.
• W1978278577 hasConcept C2780778865 @default.
• W1978278577 hasConcept C2781100745 @default.
• W1978278577 hasConcept C71924100 @default.
• W1978278577 hasConceptScore W1978278577C121608353 @default.
• W1978278577 hasConceptScore W1978278577C126322002 @default.
• W1978278577 hasConceptScore W1978278577C141071460 @default.
• W1978278577 hasConceptScore W1978278577C2776283816 @default.
• W1978278577 hasConceptScore W1978278577C2776694085 @default.
• W1978278577 hasConceptScore W1978278577C2776755627 @default.
• W1978278577 hasConceptScore W1978278577C2778239845 @default.
• W1978278577 hasConceptScore W1978278577C2780427987 @default.
• W1978278577 hasConceptScore W1978278577C2780778865 @default.
• W1978278577 hasConceptScore W1978278577C2781100745 @default.
• W1978278577 hasConceptScore W1978278577C71924100 @default.
• W1978278577 hasIssue "1" @default.
• W1978278577 hasLocation W19782785771 @default.
• W1978278577 hasLocation W19782785772 @default.
• W1978278577 hasOpenAccess W1978278577 @default.
• W1978278577 hasPrimaryLocation W19782785771 @default.
• W1978278577 hasRelatedWork W162261237 @default.
• W1978278577 hasRelatedWork W2054743947 @default.
• W1978278577 hasRelatedWork W2070829392 @default.
• W1978278577 hasRelatedWork W2091461259 @default.
• W1978278577 hasRelatedWork W2120426115 @default.
• W1978278577 hasRelatedWork W2133597285 @default.
• W1978278577 hasRelatedWork W2149068418 @default.
• W1978278577 hasRelatedWork W2154830016 @default.
• W1978278577 hasRelatedWork W2414839479 @default.
• W1978278577 hasRelatedWork W4285726302 @default.
• W1978278577 hasVolume "67" @default.
• W1978278577 isParatext "false" @default.
• W1978278577 isRetracted "false" @default.
• W1978278577 magId "1978278577" @default.
• W1978278577 workType "article" @default.